Physician

Edward Hsia0-Kua Chang, M.D.

According to 2025 Medicare claims, Edward Chang, M.D. (NPI: 1376546309) practices hematology/oncology in the Portland-Vancouver-Hillsboro, OR-WA market, with the plurality of this provider's patient population coming from Washington, OR. This provider's primary affiliated billing organization is NORTHWEST CANCER SPECIALISTS PC (NPI: 1407828114; TIN: 931280206) and primary practice location at 97223-8514.

Chang's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 366 traditional Medicare patients, billed 80,066 HCPCS/CPT codes, and received $1,218,927 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 640 prescription claims across 107 beneficiaries totaling $2,169,939 in drug costs, led by Orserdu (Elacestrant Hcl). 2016 DME data shows 26 claims. Open Payments data shows 1 records totaling $15. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $824,538 to $2,169,939. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	316	62,492	$943,485
2016	360	86,730	$1,019,170
2017	354	82,479	$922,278
2018	344	106,526	$933,704
2019	391	84,235	$964,551
2020	367	68,956	$835,558
2021	355	85,359	$1,074,422
2022	359	118,723	$1,343,406
2023	345	80,739	$1,024,238
2024	366	80,066	$1,218,927

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	140	686	$824,538
2016	157	706	$999,017
2017	132	693	$1,276,982
2018	151	849	$1,852,031
2019	135	702	$2,197,938
2020	123	705	$2,758,371
2021	111	709	$2,821,893
2022	115	606	$2,210,298
2023	106	662	$2,322,420
2024	107	640	$2,169,939

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	48	$10,936
2016	N/R	26	$1,738
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	85	155	$105
82728	Ferritin (blood protein) level	70	149	$13
80053	Blood test, comprehensive group of blood chemicals	123	360	$10
36415	Insertion of needle into vein for collection of blood sample	121	349	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	124	377	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Orserdu	Elacestrant Hcl	15	450	$364,973
Calquence	Acalabrutinib Maleate	24	720	$348,810
Revlimid	Lenalidomide	14	392	$331,753
Lenalidomide	Lenalidomide	26	728	$330,415
Jakafi	Ruxolitinib Phosphate	13	390	$217,942

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$15	Aveo Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Edward Hsia0-Kua Chang, M.D.?

Tedicare shows public-source Medicare data for Edward Hsia0-Kua Chang, M.D. (NPI 1376546309), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Edward Hsia0-Kua Chang, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Edward Hsia0-Kua Chang, M.D.?

Edward Hsia0-Kua Chang, M.D. is linked to NORTHWEST CANCER SPECIALISTS PC (billing NPI 1407828114) in the available physician profile data.

Does Edward Hsia0-Kua Chang, M.D. have Open Payments data?

Edward Hsia0-Kua Chang, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.